$NVCR NovoCure Ltd Insider Trading Week 20/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 20/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2019 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Grant | A | 0.00 | 3,359 | 0 | 3,359 | 0 to 3.4 K |
| May 24 2019 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Grant | A | 0.00 | 3,359 | 0 | 3,359 | 0 to 3.4 K |
| May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Grant | A | 0.00 | 3,359 | 0 | 69,504 | 66.1 K to 69.5 K (+5.08 %) |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Grant | A | 0.00 | 3,359 | 0 | 258,589 | 255.2 K to 258.6 K (+1.32 %) |
| May 24 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
| May 24 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Grant | A | 0.00 | 3,359 | 0 | 12,265 | 8.9 K to 12.3 K (+37.72 %) |
| May 22 2019 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | Burkoth William T. | Director | Buy | M | 48.87 | 6,145 | 300,306 | 6,145 | 0 to 6.1 K |
| May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 48.87 | 6,145 | 300,306 | 66,145 | 60 K to 66.1 K (+10.24 %) |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | VERNON W ANTHONY | Director | Buy | M | 48.87 | 6,145 | 300,306 | 255,230 | 249.1 K to 255.2 K (+2.47 %) |
| May 22 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | PHILLIPS CHARLES G III | Director | Buy | M | 48.87 | 6,145 | 300,306 | 6,145 | 0 to 6.1 K |
| May 22 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Option Exercise | M | 0.00 | 8,906 | 0 | 0 | |
| May 22 2019 | NVCR | NovoCure Ltd | Madden Martin J. | Director | Buy | M | 48.87 | 8,906 | 435,236 | 8,906 | 0 to 8.9 K |